Advertisement
Cleveland Clinic joins PATHFINDER, a promising multi-center study
Results point to lymphovascular space invasion as marker for poorer prognosis
Regional integration, process improvement, ongoing study
Effects of microbiome dysbiosis on pediatric cancer and treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Even high-risk patients see long-term benefit
Study examines the relationship between outcomes and delay
New study examines rates of downgrading in patients with aggressive prostate cancer
New research elucidates key role of WISP1 protein
Clinical indications, how it's filling a void in diagnostic care and more
Many approaches won’t delay therapy
Advertisement
Advertisement